Pelster, M., Raghav, K. P. S., Berlin, J., Morgensztern, D., Kim, S. S., Gold, P. J., Vu, P., Drees, J., Lightcap, E., Harrison, B., Zhang, W., Chan, A. S., Dudgeon, C., LaCayo, A., Karim, D., Gargano, M. A., Bose, N. (2026). Pharmacokinetics and pharmacodynamics of the GCN2 activator HC-7366 in a phase 1a study in patients with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15103